TIME Culture

Martin Shkreli Is Auctioning Off a Chance to Punch Him in the Face

Ex-pharmaceutical executive Martin Shkreli exits the U.S. District Court for the Eastern District of New York, June 6, 2016, in the Brooklyn borough of New York City.
Drew Angerer/Getty Images Ex-pharmaceutical executive Martin Shkreli exits the U.S. District Court for the Eastern District of New York, June 6, 2016, in the Brooklyn borough of New York City.

Bidding is supposedly up to $78,000

Martin Shkreli — the former Turing Pharmaceuticals CEO who gained notoriety for raising the price of an AIDS drug more than 50-fold — is now auctioning off the opportunity to punch him in the face for charity.

The man took to Twitter Monday to announce that he would grant the highest bidder one chance to punch or slap him in the face to benefit the family of his recently deceased PR consultant Mike Kulich, who died in his sleep Saturday morning. “I will auction one slap/punch in the face to benefit my friend Mike who passed away & leaves behind a young son who survived cancer,” he wrote.

He tweeted again shortly afterwards to say that he had already received bids of both $78,000 and $25,500, and the listing is now closed while he appears to search for another platform.

Shkreli was arrested in December on allegations of securities fraud. At a hearing in July, a federal judge set his trial date for June 26, 2017.

Tap to read full story

Your browser is out of date. Please update your browser at http://update.microsoft.com


YOU BROKE TIME.COM!

Dear TIME Reader,

As a regular visitor to TIME.com, we are sure you enjoy all the great journalism created by our editors and reporters. Great journalism has great value, and it costs money to make it. One of the main ways we cover our costs is through advertising.

The use of software that blocks ads limits our ability to provide you with the journalism you enjoy. Consider turning your Ad Blocker off so that we can continue to provide the world class journalism you have become accustomed to.

The TIME Team